| Pharmaceutical active ingredients: |
| Dihydroergotamine MesylateHeparin SodiumLidocaine Hydrochloride |
| Available forms, composition and doses of Embolex: |
| Injectable; Injection; Dihydroergotamine Mesylate 0.5 mg; Heparin Sodium 2,500 units; Lidocaine Hydrochloride 5.33 mg / 0.5 mlInjectable; Injection; Dihydroergotamine Mesylate 0.5 mg; Heparin Sodium 5,000 units; Lidocaine Hydrochloride 7.46 mg / 0.7 ml |
| Embolex medical category: |
| Human |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N02CA51 - Dihydroergotamine, combinations |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Novartis |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Effortil Plus | Dihydroergotamine Mesylate; Etilefrine Hydrochloride | Boehringer Ingelheim |
| Effortil Plus Perlongetten | Dihydroergotamine Mesylate; Etilefrine Hydrochloride | Boehringer Ingelheim |
| Ergolefrin | Dihydroergotamine Mesylate; Etilefrine Hydrochloride | Gepepharm |
| Ergomimet Plus | Dihydroergotamine Mesylate; Etilefrine Hydrochloride | Fujisawa |
| Hypodyn | Dihydroergotamine Mesylate; Etilefrine Hydrochloride | Novartis |
| Orstanorm med Heparin | Dihydroergotamine Mesylate; Heparin Sodium; Lidocaine Hydrochloride | Novartis; Sandoz |
| Optalidon Special NOC | Dihydroergotamine Mesylate; Propyphenazone | Novartis |
| Venelbin | Dihydroergotamine Mesylate; Troxerutin | Sanofi-Aventis |
| Divegal | Dihydroergotamine Tartrate | Sanochemia Pharmazeutika |
| Veno | Dihydroergotamine Tartrate; Troxerutin | Sanochemia Pharmazeutika |